Netherlands In-Vitro Diagnostic Market is predicted to reach USD 1.30 Billion by 2030

According to the study by Next Move Strategy Consulting, the Netherlands In-Vitro Diagnostics Market size is predicted to reach USD 1.30 billion, at a CAGR of 4.0% by 2030.

Request a FREE Sample: https://www.nextmsc.com/netherlands-in-vitro-diagnostic-market/request-sample

The increasing healthcare spending significantly drives the growth of the in-vitro diagnostics market in the nation.

The introduction of new diagnostics products in the Netherlands is anticipated to fuel the expansion of the in-vitro diagnostics market in the region throughout the forecast period.

The promising players operating in the Netherlands in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.